| Literature DB >> 30664476 |
Robert Deisz1, Susanne Rademacher1, Katrin Gilger1, Rudolf Jegen2, Barbara Sauerzapfe3, Christina Fitzner4, Christian Stoppe1, Carina Benstoem1, Gernot Marx1.
Abstract
BACKGROUND: Sepsis is a major health care problem with high morbidity and mortality rates and affects millions of patients. Telemedicine, defined as the exchange of medical information via electronic communication, improves the outcome of patients with sepsis and decreases the mortality rate and length of stay in the intensive care unit (ICU). Additional telemedicine rounds could be an effective component of performance-improvement programs for sepsis, especially in underserved rural areas and hospitals without ready access to critical care physicians.Entities:
Keywords: SSC; intensive care; outcome improvement; sepsis; sepsis bundle compliance; tele-ICU; telemedicine
Mesh:
Year: 2019 PMID: 30664476 PMCID: PMC6350091 DOI: 10.2196/11161
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 5.428
Figure 1Outline of the telemedicine center and the participating ICUs. ICU: intensive care unit, VPN: virtual private network.
Study characteristics.
| Study characteristics | Quarter 1, n (%) | Quarter 2, n (%) | Quarter 3, n (%) | Quarter 4, n (%) | Quarter 5, n (%) | Quarter 6, n (%) | Total (N) |
| Telemedicine rounds | 541 (11.84) | 596 (13.04) | 953 (20.86) | 812 (17.77) | 1074 (23.50) | 593 (12.98) | 4569 |
| Infection and sepsis screenings | 424 (9.70) | 591 (13.51) | 990 (22.64) | 775 (17.72) | 1030 (23.55) | 563 (12.87) | 4373 |
| Scorings (SAPSa II and SOFAb) | 541 (11.84) | 596 (13.04) | 953 (20.86) | 812 (17.77) | 1074 (23.51) | 593 (12.98) | 4569 |
| Diagnostic recommendations | 90 (12.21) | 77 (10.45) | 162 (21.98) | 108 (14.65) | 203 (27.54) | 97 (13.16) | 737 |
| Therapeutic recommendations | 111 (9.28) | 82 (6.85) | 285 (23.82) | 202 (16.89) | 363 (30.35) | 153 (12.79) | 1196 |
| Total 3-h and 6-h bundles | 20 (10.20) | 18 (9.18) | 36 (18.37) | 41 (20.92) | 60 (30.61) | 21 (10.71) | 196 |
| Severe sepsis or septic shock detections | 20 (10.20) | 18 (9.18) | 36 (18.37) | 41 (20.92) | 60 (30.61) | 21 (10.71) | 196 |
| Mortality | 10/20 (50) | 8/18 (44.44) | 14/36 (38.88) | 10/41 (24.39) | 14/60 (23.33) | 7/21 (33.33) | 63 |
aSAPS: Simplified Acute Physiology Score.
bSOFA: Sepsis-related Organ Failure Assessment.
Characteristics of patients with severe sepsis and septic shock.
| Patient characteristics | Initiation of telemedicine rounds, Quarter 1 (n=20) | After implementation in Quarter 5 (n=60) | After implementation in Quarter 6 (n=21) | ||
| Comparison between Q1 and Q5 | Comparison between Q1 and Q6 | ||||
| Patients with severe sepsis, n (%) | 10 (50.0) | 34 (56.7)a | 6 (28.6)b | .62 | .21 |
| Patients with septic shock, n (%) | 10 (50.0) | 26 (43.3)a | 15 (71.4)b | .62 | .21 |
| Mortality, n (%) | 10 (50.0) | 14 (23.3)a | 7 (33.3)b | .35 | |
| LOSc ICUd (days), mean (SD) | 18.2 (21.6) | 15.65 (15.5)a | 19.48 (21.4)b | .63 | .85 |
| LOS ICU after diagnosis of sepsis (days), mean (SD) | 15.65 (21.1) | 13.22 (13.9)a | 16.76 (20.7)b | .64 | .87 |
| SAPSe II, mean (SD) | 44.35 (12.1) | 44.16 (16.4)a | 45.76 (14.4)b | .96 | .74 |
| SOFAf, mean (SD) | 7.7 (3.1) | 7.18 (3.9)a | 7.52 (3.6)b | .55 | .86 |
aComparison between Q1 and Q5.
bComparison between Q1 and Q6.
cLOS: length of stay.
dICU: intensive care unit.
eSAPS: Simplified Acute Physiology Score.
fSOFA: Sepsis-related Organ Failure Assessment.
Impact of telemedicine rounds on adherence to sepsis bundles.
| Parameters | Quarter 1a (N=20), n (%) | Quarter 6b (N=21), n (%) | |||||
| Compliance to the 3-h bundle | 7 (35.0) | 16 (76.2) | .01 | ||||
| Compliance to the 6-h bundle | 10 (50.0) | 20 (95.2) | .001 | ||||
| Serum lactate measurement | 20 (100.0) | 21 (100.0) | >.99 | ||||
| Blood cultures before antibiotics | 11 (55.0) | 16 (76.2) | .20 | ||||
| Administration of antibiotics within the first 3 h | 19 (95.0) | 21 (100.0) | .49 | ||||
| Administration of fluids during hypotension | 16 (80.0) | 21 (100.0) | .049 | ||||
| Administration of vasopressors when indicated | 18 (90.0) | 20 (95.2) | .61 | ||||
| CVPc >8 mmHg | 16 (80.0) | 19 (90.5) | .34 | ||||
| ScvO2d >70% | 5 (25.0) | 9 (42.9) | .33 | ||||
| Administration of vasopressors when indicated | 18 (90.0) | 20 (95.2) | .61 | ||||
| Assessment of CVP when indicated | 16 (80.0) | 19 (90.5) | .41 | ||||
| Assessment of ScvO2 when indicated | 4 (20.0) | 9 (42.9) | .18 | ||||
| Remeasurement of lactate | 13 (65.0) | 21 (100.0) | .003 | ||||
aInitiation of telemedicine rounds.
bAfter implementation of additional rounds.
cCVP: central venous pressure.
dScvO2: central venous oxygen saturation.
Figure 2Impact of additional telemedicine rounds on adherence to sepsis bundles.
Figure 3Impact of additional telemedicine rounds on mortality.